Pilot study of the efficacy of double-blind, placebo-controlled one-week olanzapine stabilization therapy in heterogeneous symptomatic bipolar disorder patients

Journal of Psychiatric Research

Volumn 46, Issue 7, 2012, Pages 920-926

  Srivastava, Shefali ^a   Wang, Po W ^a   Hill, Shelley J ^a   Childers, Meredith E ^a   Keller, Kristine L ^a   Ketter, Terence A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar; Brief therapy; Olanzapine; Pilot study; Treatment

Indexed keywords

ATOMOXETINE; BENZODIAZEPINE; LAMOTRIGINE; LITHIUM; MODAFINIL; OLANZAPINE; OXCARBAZEPINE; PLACEBO; VALPROIC ACID;

ADULT; APPETITE DISORDER; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEMORY DISORDER; ONSET AGE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SEDATION; SIDE EFFECT; TREATMENT DURATION; TREMOR; XEROSTOMIA; YOUNG MANIA RATING SCALE;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 84861998883     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.04.004     Document Type: Article

References (23)

1. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 1976, 33:766-771.
2. Goldberg J.F., Brooks J.O., Kurita K., Hoblyn J.C., Ghaemi S.N., Perlis R.H., et al. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. Journal of Clinical Psychiatry 2009, 70:155-162.
3. Gonzalez-Isasi A., Echeburua E., Liminana J.M., Gonzalez-Pinto A. Predictors of good outcome in patients with refractory bipolar disorder after a drug or a drug and cognitive-behavioral treatment. Comprehensive Psychiatry 2012, 53:224-229.
4. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology 1959, 32:50-55.
5. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry 1960, 12:56-62.
6. Janenawasin S., Wang P.W., Lembke A., Schumacher M., Das B., Santosa C.M., et al. Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders. Bipolar Disorders 2002, 4:328-334.
7. Ketter T.A. Handbook of diagnosis and treatment of bipolar disorder 2010, American Psychiatric Publishing, Inc., Washington, DC.
8. Ketter T.A., Citrome L., Wang P.W., Culver J.L., Srivastava S. Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?. Acta Psychiatrica Scandinavica 2011, 123:175-189.
9. Leon A.C., Davis L.L., Kraemer H.C. The role and interpretation of pilot studies in clinical research. Journal of Psychiatric Research 2011, 45:626-629.
10. Lipkovich I., Citrome L., Perlis R., Deberdt W., Houston J.P., Ahl J., et al. Early predictors of substantial weight gain in bipolar patients treated with olanzapine. Journal of Clinical Psychopharmacology 2006, 26:316-320.
11. Lipkovich I.A., Houston J.P., Ahl J. Identifying patterns in treatment response profiles in acute bipolar mania: a cluster analysis approach. BMC Psychiatry 2008, 8:65.
12. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979, 134:382-389.
13. Sachs G.S., Guille C., McMurrich S.L. A clinical monitoring form for mood disorders. Bipolar Disorders 2002, 4:323-327.
14. Sachs G.S., Thase M.E., Otto M.W., Bauer M., Miklowitz D., Wisniewski S.R., et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biological Psychiatry 2003, 53:1028-1042.
15. Spearing M.K., Post R.M., Leverich G.S., Brandt D., Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Research 1997, 73:159-171.
16. Thabane L., Ma J., Chu R., Cheng J., Ismaila A., Rios L.P., et al. A tutorial on pilot studies: the what, why and how. BMC Medical Research Methodology 2010, 10:1-10.
17. Tohen M., Calabrese J.R., Sachs G.S., Banov M.D., Detke H.C., Risser R., et al. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. American Journal of Psychiatry 2006, 163:247-256.
18. Tohen M., Chengappa K.N., Suppes T., Zarate C.A., Calabrese J.R., Bowden C.L., et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Archives of General Psychiatry 2002, 59:62-69.
19. Tohen M., Jacobs T.G., Grundy S.L., McElroy S.L., Banov M.C., Janicak P.G., et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Archives of General Psychiatry 2000, 57:841-849.
20. Tohen M., Sanger T.M., McElroy S.L., Tollefson G.D., Chengappa K.N., Daniel D.G., et al. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. American Journal of Psychiatry 1999, 156:702-709.
21. Tohen M., Vieta E., Calabrese J., Ketter T.A., Sachs G., Bowden C., et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Archives of General Psychiatry 2003, 60:1079-1088.
22. Welge J.A., Keck P.E., Meinhold J.M. Predictors of response to treatment of acute bipolar manic episodes with divalproex sodium or placebo in 2 randomized, controlled, parallel-group trials. Journal of Clinical Psychopharmacology 2004, 24:607-612.
23. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 1978, 133:429-435.